NIH Cancels Neonatal Herpes Meeting

I received a phone call tonight from one of physicians who signed the letter protesting the National Institutes of Health neonatal herpes conference because of flagrant conflicts of interest among the presenters. Apparently, the top brass at NIH has canceled the meeting. If this turns out to be accurate, the question becomes: What will the agency's policy be for future clinical practice guideline writing committees? Will they require that all such committees be free of ties to companies with a stake in the outcome?